Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Biofunctional organic nanocrystals for quantitative detection of pathogen deoxyribonucleic acid

Waiting a day or more to get lab results back from the doctor's office soon could become a thing of a past.

4 Dec 2006

Australia to provide Gardasil at no cost to girls and women ages 12 to 26

Australian Prime Minister John Howard on Wednesday announced that the government will provide about $342 million for a program that will offer Merck's human papillomavirus vaccine Gardasil at no cost to girls and women ages 12 to 26 living in the country, Bloomberg reports.

2 Dec 2006

New Hampshire to provide Gardasil at no cost to girls

New Hampshire Department of Health and Human Services officials on Wednesday announced plans to become the first state to provide Merck's human papillomavirus vaccine Gardasil at no cost to girls ages 11 to 18 as part of a state program that offers immunizations to minors, the AP/Nashua Telegraph reports.

2 Dec 2006

Cigarette smoking and high HPV concentrations associated with greater risk of cervical cancer

Cigarette smoking and concurrent infection with high levels of the virus associated with cervical cancer can increase cancer risk by as much as 27 times, according to a study published in the November 2006 issue of Cancer Epidemiology, Biomarkers & Prevention.

19 Nov 2006

40% of U.S. women ages 18 to 75 know about human papillomavirus

Forty percent of U.S. women ages 18 to 75 have heard about human papillomavirus and of those women, 20% are aware that it can cause cervical cancer, according to the National Cancer Institute's 2005 Health Information National Trends Survey, which was presented on Sunday at the American Association for Cancer Research's Frontiers in Cancer Prevention Research Meeting in Boston, Reuters Health reports.

14 Nov 2006

Cervical cancer vaccine to be included in school vaccination program in the U.S.

The U.S. government has added a new vaccine which protects girls and women from from cervical cancer to their subsidized vaccine program for schoolchildren.

2 Nov 2006

HPV test is a better long-term predictor of cervical cell abnormalities than pap smear

The best initial cervical cancer screening tool for younger women is still the traditional Pap smear. However, a large Danish study has found that for older women (age 40 and older), a test for human papillomavirus (HPV) is a much more effective way to screen for potential cancer.

1 Nov 2006

Sanofi Pasteur begins selling Gardasil in six E.U. countries

Sanofi Pasteur, a joint company of Merck and Sanofi-Aventis, recently began selling Merck's human papillomavirus vaccine Gardasil in Austria, Finland, Germany, Ireland, Sweden and the United Kingdom, Reuters reports (Reuters, 10/17).

19 Oct 2006

Michigan Senate approves bills that would require girls to receive HPV vaccine before entering sixth grade

The Michigan Senate on Wednesday voted 36-1 to approve two bills (SB 1416, SB 1417) that would require girls in the state entering the sixth grade in the 2007-2008 school year and beyond to have received Merck's human papillomavirus vaccine Gardasil, the AP/Detroit Free Press reports (AP/Detroit Free Press, 9/20).

26 Sep 2006

HPV vaccine Gardasil approved for sale in EU

The European Commission on Friday approved Merck's human papillomavirus vaccine Gardasil for sale and marketing in the European Union, London's Guardian reports (Batty, Guardian, 9/22).

26 Sep 2006

Cell detachment model for an antibody-based microfluidic cancer screening system

In the quest to detect more types of cancers at ever earlier stages, researchers have been stymied by a lack of cell surface markers that distinguish in a clear-cut manner between healthy and malignant cells.

19 Sep 2006

Michigan Bills introduced that would require girls to receive HPV vaccine before sixth grade

Michigan Sen. Beverly Hammerstrom (R) last Tuesday introduced two bills (SB 1416, SB 1417) that would require girls in the state entering the sixth grade in the 2007-2008 school year and beyond to have received Merck's human papillomavirus vaccine Gardasil, the Detroit News reports.

18 Sep 2006

AIDS Vaccines: The Next Frontiers

The AIDS Vaccine Advocacy Coalition on Thursday released its annual report, titled "AIDS Vaccines: The Next Frontiers," which says that without sufficient future planning, AIDS vaccine research could be slowed.

18 Sep 2006

Women in Government back cervical cancer vaccine for sixth graders

Girls in Michigan as young as eleven years could be the first required to be vaccinated against cervical cancer under proposed mandatory legislation.

18 Sep 2006

Fewer deaths from cancer in the U.S.

According to a new report fewer Americans are dying of cancer even though the rates of new cancers remains the same.

7 Sep 2006

Cervical cancer vaccines offer broader cancer protection

Researchers now believe the first ever cervical cancer vaccine may provide even more protection against the killer disease than first thought.

4 Sep 2006

Some parents have difficulties gaining access to insurance coverage for HPV vaccine Gardasil

Some parents seeking to vaccinate their daughters with Merck's human papillomavirus vaccine Gardasil have experienced difficulty in obtaining it or getting it covered by health insurance, the AP/Seattle Post-Intelligencer reports (Tanner, AP/Seattle Post-Intelligencer, 8/29).

1 Sep 2006

Antiretroviral drug Lopinavir selectively kills HPV-infected cells in lab tests

The protease inhibitor lopinavir - the primary component of Abbott Laboratories' antiretroviral drug Kaletra - selectively killed the human papillomavirus in laboratory tests, according to a study scheduled to be published next month in the journal Anti-Viral Therapy.

From The University of Manchester 30 Aug 2006

Challenges parents, physicians face in addressing HPV vaccine

The AP/Washington Post on Sunday examined the challenges parents and physicians face in addressing the issues associated with Merck's human papillomavirus vaccine Gardasil (Irvine, AP/Washington Post, 8/27).

30 Aug 2006

History of cervical cancer, HPV vaccine development

The New York Times on Tuesday examined the development of vaccines to prevent transmission of the human papillomavirus, which can cause cervical cancer.

30 Aug 2006

Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Biofunctional organic nanocrystals for quantitative detection of pathogen deoxyribonucleic acid

Australia to provide Gardasil at no cost to girls and women ages 12 to 26

New Hampshire to provide Gardasil at no cost to girls

Cigarette smoking and high HPV concentrations associated with greater risk of cervical cancer

40% of U.S. women ages 18 to 75 know about human papillomavirus

Cervical cancer vaccine to be included in school vaccination program in the U.S.

HPV test is a better long-term predictor of cervical cell abnormalities than pap smear

Sanofi Pasteur begins selling Gardasil in six E.U. countries

Michigan Senate approves bills that would require girls to receive HPV vaccine before entering sixth grade

HPV vaccine Gardasil approved for sale in EU

Cell detachment model for an antibody-based microfluidic cancer screening system

Michigan Bills introduced that would require girls to receive HPV vaccine before sixth grade

AIDS Vaccines: The Next Frontiers

Women in Government back cervical cancer vaccine for sixth graders

Fewer deaths from cancer in the U.S.

Cervical cancer vaccines offer broader cancer protection

Some parents have difficulties gaining access to insurance coverage for HPV vaccine Gardasil

Antiretroviral drug Lopinavir selectively kills HPV-infected cells in lab tests

Challenges parents, physicians face in addressing HPV vaccine

History of cervical cancer, HPV vaccine development

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in